Evidence map›Paper›PMID 24503058›Full record

ArticleBMJ (Clinical research ed.)2014

Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data.

Joel W Hotchkiss, Carolyn A Davies, Ruth Dundas, Nathaniel Hawkins, Pardeep S Jhund, Shaun Scholes, Madhavi Bajekal, Martin O'Flaherty, Julia Critchley, Alastair H Leyland and 1 more

Open access · hybridAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. A Modeling Study for Hip Fracture Rates in Romania.Journal of clinical medicine · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2022
    Article
  8. Article
  9. Epidemiology of cardiovascular disease in Europe.Nature reviews. Cardiology · 2022
    Review
  10. Article
  11. Article
  12. Health Care Resources and 24,910 Deaths Due to Traffic Accidents: An Ecological Mortality Study in Poland.International journal of environmental research and public health · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Perceived Neighbourhood Problems over Time and Associations with Adiposity.International journal of environmental research and public health · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Joel W HotchkissSchool of Veterinary Medicine, University of Glasgow, Glasgow G61 1QH, UK.
Carolyn A Davies
Ruth Dundas
Nathaniel Hawkins
Pardeep S Jhund
Shaun Scholes
Madhavi Bajekal
Martin O'Flaherty
Julia Critchley
Alastair H Leyland
Simon Capewell
University of Glasgow · GBMRC/CSO Social and Public Health Sciences Unit · GBUniversity College London · GBUniversity of Liverpool · GBSt George's, University of London · GBUniversity of British Columbia · CA

Funding

Chief Scientist Office SPHSU2Medical Research Council G0900847Medical Research Council MC_UU_12017/5
6 · The paper itself

Abstract

objectiveTo quantify the contributions of prevention and treatment to the trends in mortality due to coronary heart disease in Scotland.

designRetrospective analysis using IMPACTSEC, a previously validated policy model, to apportion the recent decline in coronary heart disease mortality to changes in major cardiovascular risk factors and to increases in more than 40 treatments in nine non-overlapping groups of patients.

settingScotland.

participantsAll adults aged 25 years or over, stratified by sex, age group, and fifths of Scottish Index of Multiple Deprivation.

main outcome measureDeaths prevented or postponed.

results5770 fewer deaths from coronary heart disease occurred in 2010 than would be expected if the 2000 mortality rates had persisted (8042 rather than 13,813). This reflected a 43% fall in coronary heart disease mortality rates (from 262 to 148 deaths per 100,000). Improved treatments accounted for approximately 43% (95% confidence interval 33% to 61%) of the fall in mortality, and this benefit was evenly distributed across deprivation fifths. Notable treatment contributions came from primary prevention for hypercholesterolaemia (13%), secondary prevention drugs (11%), and chronic angina treatments (7%). Risk factor improvements accounted for approximately 39% (28% to 49%) of the fall in mortality (44% in the most deprived fifth compared with only 36% in the most affluent fifth). Reductions in systolic blood pressure contributed more than one third (37%) of the decline in mortality, with no socioeconomic patterning. Smaller contributions came from falls in total cholesterol (9%), smoking (4%), and inactivity (2%). However, increases in obesity and diabetes offset some of these benefits, potentially increasing mortality by 4% and 8% respectively. Diabetes showed strong socioeconomic patterning (12% increase in the most deprived fifth compared with 5% for the most affluent fifth).

conclusionsIncreases in medical treatments accounted for almost half of the large recent decline in mortality due to coronary heart disease in Scotland. Furthermore, the Scottish National Health Service seems to have delivered these benefits equitably. However, the substantial contributions from population falls in blood pressure and other risk factors were diminished by adverse trends in obesity and diabetes. Additional population-wide interventions are urgently needed to reduce coronary heart disease mortality and inequalities in future decades.

Indexed as

AdultAgedAged, 80 and overAge FactorsCoronary DiseaseFemaleHumansMaleMiddle AgedModels, StatisticalPoverty AreasRetrospective StudiesRisk FactorsScotlandSex FactorsSocioeconomic Factors

Identifiers

PMID24503058
PMCPMC3915926
OpenAlexW1967327975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.